Delayed short-term administration of granulocyte colony-stimulating factor is a good mobilization strategy for harvesting autologous peripheral blood stem cells in pediatric patients with solid tumors

Pediatric Transplantation

Volumn 17, Issue 7, 2013, Pages 688-693

  Takahashi, Hiroyoshi ^a   Kato, Motohiro ^a   Kikuchi, Akira ^a   Hanada, Ryoji ^a   Koh, Katsuyoshi ^a  

^a SAITAMA CHILDREN'S MEDICAL CENTER   (Japan)

Author keywords

CD34+ cells; childhood solid tumor; granulocyte colony stimulating factor; stem cell harvesting

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; PIRARUBICIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE;

ADOLESCENT; APHERESIS; ARTICLE; BONE MARROW METASTASIS; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CD34 SELECTION; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; FEBRILE NEUTROPENIA; FEMALE; HUMAN; INDUCTION CHEMOTHERAPY; MALE; MULTIMODALITY CANCER THERAPY; NEUROBLASTOMA; PERIPHERAL BLOOD STEM CELL; PRESCHOOL CHILD; RHABDOMYOSARCOMA; SCHOOL CHILD; SHORT COURSE THERAPY; STEM CELL MOBILIZATION;

CD34+ CELLS; CHILDHOOD SOLID TUMOR; GRANULOCYTE COLONY-STIMULATING FACTOR; STEM CELL HARVESTING;

ADOLESCENT; ANTIGENS, CD34; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; NEOPLASM METASTASIS; NEUROBLASTOMA; RETROSPECTIVE STUDIES; RHABDOMYOSARCOMA; STEM CELLS; TISSUE AND ORGAN HARVESTING; TREATMENT OUTCOME;

EID: 84885422408     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/petr.12137     Document Type: Article

References (27)

1. Peters WP, Rosner G, Ross M, et al. Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy. Blood 1993: 81: 1709-1719.
2. Haynes A, Hunter A, McQuaker G, Anderson S, Bienz N, Russell NH,. Engraftment characteristics of peripheral blood stem cells mobilised with cyclophosphamide and the delayed addition of G-CSF. Bone Marrow Transplant 1995: 16: 359-363.
3. Arpaci F, Komurcu S, Ozturk B, Ozet A, Kinalp C, Yalcin A,. The mobilization with delayed G-CSF administration after standard induction chemotherapy and single standard volume apheresis can supply adequate amount of CD34(+) cells in patients with breast cancer. Haematologica 2001: 86: E01.
4. Jacoub JF, Suryadevara U, Pereyra V, et al. Mobilization strategies for the collection of peripheral blood progenitor cells: Results from a pilot study of delayed addition G-CSF following chemotherapy and review of the literature. Exp Hematol 2006: 34: 1443-1450.
5. Villalon L, Odriozola J, Larana JG, et al. Autologous peripheral blood progenitor cell transplantation with <2 x 10(6) CD34(+)/kg: An analysis of variables concerning mobilisation and engraftment. Hematol J 2000: 1: 374-381.
6. Suita S, Tajiri T, Kaneko M, et al. Implications of MYCN amplification in patients with stage 4 neuroblastoma who undergo intensive chemotherapy. J Pediatr Surg 2007: 42: 489-493.
7. Craig JI, Langlands K, Parker AC, Anthony RS,. Molecular detection of tumor contamination in peripheral blood stem cell harvests. Exp Hematol 1994: 22: 898-902.
8. DiPersio JF, Micallef IN, Stiff PJ, et al. Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma. J Clin Oncol 2009: 27: 4767-4773.
9. Sugrue MW, Williams K, Pollock BH, et al. Characterization and outcome of "hard to mobilize"'lymphoma patients undergoing autologous stem cell transplantation. Leuk Lymphoma 2000: 39: 509-519.
10. Ikeda K, Kozuka T, Harada M,. Factors for PBPC collection efficiency and collection predictors. Transfus Apher Sci 2004: 31: 245-259.
11. Bolwell BJ, Fishleder A, Andresen SW, et al. G-CSF primed peripheral blood progenitor cells in autologous bone marrow transplantation: Parameters affecting bone marrow engraftment. Bone Marrow Transplant 1993: 12: 609-614.
12. Haas R, Mohle R, Fruhauf S, et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994: 83: 3787-3794.
13. + cells in multiple myeloma. Ann Hematol 2001: 80: 592-597.
14. Olivieri A, Offidani M, Ciniero L, et al. Optimization of the yield of PBSC for autotransplantation mobilized by high-dose chemotherapy and G-CSF: Proposal for a mathematical model. Bone Marrow Transplant 1994: 14: 273-278.
15. Drake M, Ranaghan L, Morris TC, et al. Analysis of the effect of prior therapy on progenitor cell yield: Use of a chemotherapy scoring system. Br J Haematol 1997: 98: 745-749.
16. Pusic I, Jiang SY, Landua S, et al. Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation. Biol Blood Marrow Transplant 2008: 14: 1045-1056.
17. Bensinger W, DiPersio JF, McCarty JM,. Improving stem cell mobilization strategies: Future directions. Bone Marrow Transplant 2009: 43: 181-195.
18. Donmez A, Kabaroglu C, Arik B, Tombuloglu M,. The effect of cholesterol levels on hematopoietic stem cell mobilization. Transfus Apher Sci 2012: 47: 9-12.
19. Rauck AM, Ruymann FB, Klopfenstein K, et al. Mobilization of peripheral blood stem cells in children using G-CSF after carboplatin containing myelosuppressive chemotherapy. J Clin Apher 1998: 13: 146-154.
20. + cells in two automated leukapheresis systems. Transfusion 2001: 41: 1008-1013.
21. + cell yield. Ther Apher 2002: 6: 384-389.
22. Passos-Coelho JL, Braine HG, Davis JM, et al. Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization. J Clin Oncol 1995: 13: 705-714.
23. + cell count predicts the likelihood of successful hematopoietic stem cell mobilization. Bone Marrow Transplant 2006: 38: 189-196.
24. Watanabe H, Watanabe T, Suzuya H, et al. Peripheral blood stem cell mobilization by granulocyte colony-stimulating factor alone and engraftment kinetics following autologous transplantation in children and adolescents with solid tumor. Bone Marrow Transplant 2006: 37: 661-668.
25. Greenbaum AM, Link DC,. Mechanisms of G-CSF-mediated hematopoietic stem and progenitor mobilization. Leukemia 2011: 25: 211-217.
26. Levesque JP, Takamatsu Y, Nilsson SK, Haylock DN, Simmons PJ,. Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor. Blood 2001: 98: 1289-1297.
27. Gridelli C, Aapro MS, Barni S, et al. Role of colony stimulating factors (CSFs) in solid tumours: Results of an expert panel. Crit Rev Oncol Hematol 2007: 63: 53-64.